Delivery Order SPE2DB22D3011-SPE2DB24FQ4DA
Award Date
9/27/24
Potential Completion Date
9/30/24
Potential Value
$52K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $22,627.70, is for the delivery of Teriflunomide 14 mg tablets. The contract has a period of performance through May 3, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order (SPE2DB24FQ2XV) awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of TERIFLUNOMIDE 14 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $27,248.86. The contract is a firm-fixed price arrangement and does not have a set-aside designation. The ultimate completion date for this contract is July 31, 2024. Amerisourcebergen Drug Corp is a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,163.16, is a Delivery Order for 4,566,761,020 units of Terbinafine HCL 250 mg tablets with a completion date of December 19, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,567,197,739 units of the medication teriparatide 620 mcg/2.48 ml, with a total ceiling value of $2,146.66. The contract is a firm fixed-price delivery order with a completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,667.38, is for the delivery of 4567883312 Terbinafine HCL 250 mg tablets in lots of 100. This is a firm fixed-price delivery order contract with an ultimate completion date of April 14, 2025. The contract was awarded on April 11, 2025 and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,426.53 Firm Fixed Price delivery order is for the provision of 4,566,703,844 units of Terbinafine HCl 250 mg tablets. The contract has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $10,025.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB20D2104|SPE2DB25FMLFE) with a firm fixed-price pricing type for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567904993 ORSERDU 345 MG TABLET 30S, with a ceiling value of $27,841.82 and a period of performance through May 5, 2025. This is a firm fixed price delivery order contract and is not a set-aside award. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TERLIVAZ 0.85 MG VIALS, a pharmaceutical product, with a ceiling value of $2,462.36. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 9, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $13,929.10 with a firm fixed price pricing type and a completion date of January 21, 2025. The contract provides pharmaceutical products, including the ORSERDU 345 MG TABLET 30S, to support military treatment facilities, veterans' healthcare programs, and other federal medical...